X-149482795-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM1PM2BP6

The NM_000202.8(IDS):​c.1604T>C​(p.Met535Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000273 in 1,098,257 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000027 ( 0 hom. 0 hem. )

Consequence

IDS
NM_000202.8 missense

Scores

2
7
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 7.95

Publications

0 publications found
Variant links:
Genes affected
IDS (HGNC:5389): (iduronate 2-sulfatase) This gene encodes a member of the sulfatase family of proteins. The encoded preproprotein is proteolytically processed to generate two polypeptide chains. This enzyme is involved in the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this gene are associated with the X-linked lysosomal storage disease mucopolysaccharidosis type II, also known as Hunter syndrome. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
IDS Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 2
    Inheritance: XL, AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, PanelApp Australia, Myriad Women’s Health
  • mucopolysaccharidosis type 2, attenuated form
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • mucopolysaccharidosis type 2, severe form
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_000202.8
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant X-149482795-A-G is Benign according to our data. Variant chrX-149482795-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 3711226.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IDSNM_000202.8 linkc.1604T>C p.Met535Thr missense_variant Exon 9 of 9 ENST00000340855.11 NP_000193.1 P22304-1
IDSNM_001166550.4 linkc.1334T>C p.Met445Thr missense_variant Exon 9 of 9 NP_001160022.1 P22304B4DGD7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IDSENST00000340855.11 linkc.1604T>C p.Met535Thr missense_variant Exon 9 of 9 1 NM_000202.8 ENSP00000339801.6 P22304-1
ENSG00000241489ENST00000651111.1 linkc.971T>C p.Met324Thr missense_variant Exon 14 of 14 ENSP00000498395.1 B3KWA1
ENSG00000241489ENST00000422081.6 linkc.971T>C p.Met324Thr missense_variant Exon 9 of 9 2 ENSP00000477056.1 B3KWA1

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD2 exomes
AF:
0.0000109
AC:
2
AN:
183192
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000144
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000273
AC:
3
AN:
1098257
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
363611
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26403
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.0000662
AC:
2
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54149
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40525
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
842146
Other (OTH)
AF:
0.00
AC:
0
AN:
46098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Mucopolysaccharidosis, MPS-II Uncertain:1
Dec 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 535 of the IDS protein (p.Met535Thr). This variant is present in population databases (rs782166680, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with IDS-related conditions. Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt IDS protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Benign:1
Apr 18, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.063
T
BayesDel_noAF
Uncertain
-0.070
CADD
Benign
22
DANN
Benign
0.97
DEOGEN2
Uncertain
0.48
T;.
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.51
T;T
M_CAP
Pathogenic
0.85
D
MetaRNN
Uncertain
0.47
T;T
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Benign
1.7
L;.
PhyloP100
7.9
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.9
N;.
REVEL
Uncertain
0.42
Sift
Uncertain
0.0050
D;.
Sift4G
Uncertain
0.0080
D;D
Polyphen
0.0050
B;.
Vest4
0.19
MutPred
0.53
Loss of loop (P = 0.0022);.;
MVP
0.86
MPC
0.24
ClinPred
0.29
T
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.69
gMVP
0.78
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782166680; hg19: chrX-148564326; API